ARCHIVES

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: Fredrickson Okays NCI Reorganization, Plan At Hew; Miller Leave International Affairs Job

February 8, 1980

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

HCFA Firm Against Reimbursement For Patients In Clinical Trials, Lasagna Committee Hears

March 24, 1989

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

Medenica Trial Begins In South Carolina

February 10, 1995